Suppr超能文献

肥胖型肌少症的不同诊断标准在减重手术后的中远期评估。

Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric surgery.

机构信息

Graduate Program in Human Nutrition, University of Brasilia, Campus Universitário Darcy Ribeiro, Faculdade de Ciências da Saúde, Departamento de Nutrição, Brasília, DF, 70910-900, Brazil.

Department of Agricultural, Food and Nutritional Sciences, University of Alberta, 2-004 Li Ka Shing Center for Health Research Innovation, 113 St and 87 Ave NW, Edmonton, AB, T6G 2E1, Canada.

出版信息

Clin Nutr. 2022 Sep;41(9):1932-1941. doi: 10.1016/j.clnu.2022.07.006. Epub 2022 Jul 10.

Abstract

BACKGROUND/AIMS: The aim of this study was to apply the European Society for Clinical Nutrition and Metabolism/European Association for the Study of Obesity (ESPEN/EASO) consensus to identify sarcopenic obesity (SO) in adults mid to long-term post-Roux-en-Y gastric bypass (RYGB) using both dual-energy x-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA). Further, this approach was compared to accepted sarcopenia diagnostic criteria (Revised European Working Group on Sarcopenia in Older People [EWGSOP2] and Sarcopenia Definition and Outcomes Consortium [SDOC]).

METHODS

This cross-sectional study included adults ≥2 years post-RYGB surgery. Obesity was diagnosed by excess fat mass (FM) for all diagnostic criteria. Agreement was evaluated using Cohen's Kappa.

RESULTS

We evaluated 186 participants (90.9% female, median age 43.9 years, 6.8 years post-surgery), of which 60.2% (BIA), and 83.3% (DXA) had excess FM. Low muscle strength was not identified using absolute handgrip strength. The prevalence of SO by BIA or DXA, respectively, was 7.9% (95%CI 3.9-12.5), and 23.0% (95%CI 17.1-30.3) [ESPEN/EASO SO consensus]; 0.7% (95%CI 0-2.0), and 3.3% (95%CI 0.7-5.9) [EWGSOP2]; and 27.0% (95%CI 19.7-34.2), and 30.3% (95%CI 23.0-37.5) [SDOC]. Agreement between the ESPEN/EASO SO consensus and other diagnostic criteria was none to slight using DXA: EWGSOP2 k = 0.19; 95% CI 0.04-0.34, or SDOC k = 0.16; 95% CI -0.01-0.32. Moderate agreement was observed within the ESPEN/EASO SO consensus for BIA and DXA (k = 0.43; 95% CI 0.26-0.60).

CONCLUSIONS

This is the first study to explore the prevalence of SO using the ESPEN/EASO criteria. We identified a high but variable prevalence of SO in post-bariatric surgery patients (7.9-23.0%), depending on the body composition technique used; prevalence was higher using DXA. Little agreement was observed for the diagnosis of SO using the three diagnostic criteria. Future studies are needed to explore the relationship between SO identified by the ESPEN/EASO consensus and health status/outcomes.

摘要

背景/目的:本研究旨在应用欧洲临床营养与代谢学会/欧洲肥胖研究协会(ESPEN/EASO)共识,使用双能 X 射线吸收法(DXA)和生物电阻抗分析(BIA)来确定成人接受 Roux-en-Y 胃旁路术(RYGB)后中长期的肌少性肥胖(SO)。此外,还将这种方法与公认的肌少症诊断标准(修订的欧洲老年人肌少症工作组 [EWGSOP2] 和肌少症定义和结局联合会 [SDOC])进行了比较。

方法

本横断面研究纳入了接受 RYGB 手术后≥2 年的成年人。所有诊断标准均通过过量脂肪量(FM)来诊断肥胖。使用 Cohen's Kappa 评估一致性。

结果

我们评估了 186 名参与者(90.9%为女性,中位年龄 43.9 岁,手术后 6.8 年),其中 60.2%(BIA)和 83.3%(DXA)存在过量 FM。绝对握力无法识别出低肌肉力量。通过 BIA 或 DXA 分别确定 SO 的患病率为 7.9%(95%CI 3.9-12.5)和 23.0%(95%CI 17.1-30.3)[ESPEN/EASO SO 共识];0.7%(95%CI 0-2.0)和 3.3%(95%CI 0.7-5.9)[EWGSOP2];27.0%(95%CI 19.7-34.2)和 30.3%(95%CI 23.0-37.5)[SDOC]。ESPEN/EASO SO 共识与其他诊断标准之间的一致性使用 DXA 时为无到轻度:EWGSOP2 k=0.19;95%CI 0.04-0.34,或 SDOC k=0.16;95%CI -0.01-0.32。在 BIA 和 DXA 中,ESPEN/EASO SO 共识内观察到中度一致性(k=0.43;95%CI 0.26-0.60)。

结论

这是第一项使用 ESPEN/EASO 标准探讨 SO 患病率的研究。我们发现,根据使用的身体成分技术,接受减重手术后患者的 SO 患病率很高但变化较大(7.9-23.0%);使用 DXA 时患病率更高。使用三种诊断标准对 SO 的诊断一致性较差。需要进一步研究来探讨 ESPEN/EASO 共识确定的 SO 与健康状况/结局之间的关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验